Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 13;7(4):20552173211061550. doi: 10.1177/20552173211061550

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2021

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Patient disposition

*as percentage of intent-to-treat patients; **as percentage of patients in PC phase at start of Year 1; ***as percentage of patients in OLE phase after Year 1.

DS: delayed start; ES: early start; GA40: glatiramer acetate 40 mg/mL subcutaneous injection administered three times weekly; OLE: open-label extension; PC: placebo-controlled.